Vital Innovations Holdings Ltd. (6133) AI Stock Analysis

• Market Cap: HK$161.50M
• Dividend Yield: N/A
• Average Volume (3M): 54.30K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.15
• Revenue Growth: 3.70%
• EPS Growth: 5.90%
• Country: HK
• Employees: 24
• Sector: Technology
• Sector Strength: 88
• Industry: Consumer Electronics
• EPS (TTM): -0.01
• Shares Outstanding: 850,000,000
• 10 Day Avg. Volume: 11,000
• 30 Day Avg. Volume: 54,300
• PEG Ratio: -7.17
• Price to Book (P/B): 0.25
• Price to Sales (P/S): 0.12
• P/FCF Ratio: -11.13
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: HK$0.20 ▲(8.89% Upside)

Vital Innovations Holdings Ltd. is facing significant financial challenges, with persistent net losses and negative margins impacting its overall score. Technical analysis shows some short-term bullish momentum, but valuation metrics are poor due to a negative P/E ratio and lack of dividend yield. The absence of earnings call data and corporate events means these factors do not influence the score.

Positive Factors

Low leverage and strong equity base

A low debt burden and stable equity base materially reduce solvency and refinancing risk, giving the company durable financial flexibility. This structural balance-sheet strength supports continued investment in operations or R&D and improves resilience during industry downturns.

Consistent revenue growth

Sustained top-line growth, even modest, indicates product or market traction in consumer electronics. Over months this provides scale benefits: spreading fixed costs, enabling incremental investment in distribution or product development, and creating a platform for margin recovery if maintained.

Improving free cash flow

Evidence of improving free cash flow reflects progress in working-capital and cash management. If sustained, stronger FCF lessens reliance on external financing, extends operational runway, and funds strategic initiatives—improving long-term viability independent of short-term market moves.

Negative Factors

Persistent net losses

Ongoing net losses undermine the company’s ability to self-fund growth and erode return metrics. Over time this limits capital allocation options, forces dependence on external funding, and raises execution risk for strategic plans, making sustainable recovery of profitability imperative.

Negative and volatile operating cash flow

Continued negative and unstable operating cash flow constrains liquidity and operational flexibility. Structurally, this increases the likelihood of recurring financing needs, limits reinvestment capacity, and heightens vulnerability to demand or supply shocks over the medium term.

Weak gross and operating margins

Sustained weak gross and negative EBIT/EBITDA margins point to structural cost or pricing shortfalls in core operations. Long-term competitiveness and cash generation are impaired unless the company meaningfully improves unit economics or reconfigures cost structure to restore profit margins.

Vital Innovations Holdings Ltd. Business Overview & Revenue Model

Company Description

Vital Innovations Holdings Limited, an investment holding company, designs, develops, manufactures, and sells mobile handsets in Hong Kong. It offers mobile phones, smartphones, and mobile telecommunication related components and accessories, as well as supply chain management, logistics, and other related mobile telecommunication services. The company serves mobile handset suppliers, telecommunication operators, and trading companies in South Asia, Southeast Asia, rest of Asia, Europe, North America, South America, and Africa. It also sells AI and other equipment. The company was formerly known as Vital Mobile Holdings Limited and changed its name to Vital Innovations Holdings Limited in July 2019. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China. Vital Innovations Holdings Limited is a subsidiary of Winmate Limited.

How the Company Makes Money

Vital Innovations Holdings Ltd. generates revenue through multiple streams, primarily by investing in early-stage companies within its sectors and taking equity stakes in these businesses. The company monetizes its investments through capital gains as these companies grow and either get acquired or go public. Additionally, Vital Innovations earns income from licensing agreements for its proprietary technologies and products developed in-house. Strategic partnerships with healthcare providers, research institutions, and technology firms further bolster its revenue, allowing for collaborative projects that drive innovation and market penetration. The company also benefits from government grants and funding aimed at fostering advancements in health technology.

Vital Innovations Holdings Ltd. Financial Statement Overview

Summary

Vital Innovations Holdings Ltd. faces significant profitability challenges, with persistent net losses and negative margins across the board. While the balance sheet reflects low leverage, the lack of profitability impacts return metrics negatively. Cash flow management shows some improvements, but the company still struggles to generate positive operating cash flows.

Income Statement

Vital Innovations Holdings Ltd. has shown a fluctuating revenue trend, with a recent increase in revenue but continued negative profitability. The gross profit margin remains weak, and net profit margins are negative, indicating ongoing operational challenges. EBIT and EBITDA margins are also negative, reflecting the company's struggle to cover operating costs effectively.

Balance Sheet

The company's balance sheet shows a relatively stable equity position, with a low debt-to-equity ratio indicating minimal leverage risk. However, the return on equity is negative due to consistent net losses. The equity ratio remains strong, suggesting a solid equity base compared to total assets.

Cash Flow

Cash flow analysis reveals volatile operating cash flows, with recent improvements in free cash flow indicating better cash management. However, the operating cash flow remains negative, and the cash flow ratios indicate challenges in converting income into cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	792.56M	1.06B	835.61M	1.09B	672.65M	881.14M
Gross Profit	4.76M	5.95M	3.01M	4.70M	-486.00K	-79.57M
EBITDA	-13.58M	-18.02M	-18.12M	-15.44M	-19.07M	-95.42M
Net Income	-15.89M	-21.00M	-20.84M	-17.46M	-20.50M	-97.63M
Balance Sheet
Total Assets	598.59M	614.60M	628.86M	620.41M	640.56M	710.60M
Cash, Cash Equivalents and Short-Term Investments	7.83M	8.20M	24.35M	37.58M	26.65M	54.37M
Total Debt	24.89M	30.63M	34.00M	9.00M	15.37M	21.12M
Total Liabilities	124.69M	132.28M	125.61M	96.32M	98.91M	148.38M
Stockholders Equity	473.89M	482.31M	503.31M	524.15M	541.70M	562.20M
Cash Flow
Free Cash Flow	-6.10M	-11.05M	-40.50M	15.46M	-19.72M	3.91M
Operating Cash Flow	-6.10M	-11.05M	-40.49M	15.46M	-19.72M	3.91M
Investing Cash Flow	3.60M	3.59M	-58.00K	-219.00K	137.00K	12.00K
Financing Cash Flow	-1.76M	-8.68M	26.85M	-7.05M	-9.08M	-758.00K

Vital Innovations Holdings Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.18
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6133, the sentiment is Negative. The current price of 0.18 is below the 20-day moving average (MA) of 0.20, below the 50-day MA of 0.21, and below the 200-day MA of 0.25, indicating a bearish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 35.80 is Neutral, neither overbought nor oversold. The STOCH value of 40.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:6133.

Vital Innovations Holdings Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
0912	66 Neutral	HK$299.03M	9.31	4.09%	7.62%	6.84%	-0.96%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
0927	54 Neutral	HK$316.82M	-4.73	-11.41%	8.70%	-16.95%	-461.16%
1747	54 Neutral	HK$2.62B	72.41	15.73%	0.50%	11.29%	40.42%
6133	46 Neutral	HK$161.50M	-7.45	-4.14%	―	3.70%	5.90%
8005	46 Neutral	HK$196.53M	-1.36	-8.93%	―	-59.19%	-159.11%
2369	40 Underperform	HK$252.27M	-1.28	-13.04%	―	8.62%	-24.87%

Vital Innovations Holdings Ltd. Corporate Events

Vital Innovations Relocates Principal Place of Business in Hong Kong

Vital Innovations Holdings Limited has announced that its principal place of business in Hong Kong will be relocated to Room 2210, 22/F, Hong Kong Plaza, 188 Connaught Road West, Hong Kong, effective 16 January 2026. The move, approved and announced by the company’s board, is an operational change in its Hong Kong presence that may affect how stakeholders and business partners engage with the company’s local office but does not signal any change in its corporate structure or governance, which remains overseen by a board comprising both executive and independent non-executive directors.

The most recent analyst rating on (HK:6133) stock is a Hold with a HK$0.24 price target. To see the full list of analyst forecasts on Vital Innovations Holdings Ltd. stock, see the HK:6133 Stock Forecast page.

Vital Innovations Announces Key Leadership Changes

Vital Innovations Holdings Limited has announced a change in its company secretary, authorized representative, and process agent roles following the unexpected passing of Mr. Chui Man Lung Everett. Mr. Cheng Chi Chung Kevin has been appointed to these positions, bringing over 14 years of experience in company secretarial services and compliance. This transition is significant for the company’s operations as it ensures continuity in governance and compliance functions, which are crucial for maintaining its standing on the Hong Kong Stock Exchange.

The most recent analyst rating on (HK:6133) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Vital Innovations Holdings Ltd. stock, see the HK:6133 Stock Forecast page.